Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THC Effects on Reward in Young Adults
NCT04512365Phase 1Completed
- Sponsor
- University of Illinois Chicago
- Start
- Mar 2021
- Primary completion
- May 2025
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dronabinol in cannabis use disorder (CUD), sponsored by University of Illinois Chicago. Primary endpoints: Reward Positivity at 120 months and blood-oxygen-level-dependent response at 120 months. Started Mar 2021; status: completed.
02
Drugs
dronabinol
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT04512365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04512365.